Overview
Subacute cutaneous lupus erythematosus (SCLE) is a variant of systemic lupus erythematosus characterized by skin manifestations, often without significant internal organ involvement. 1Diagnosis
Clinical Features: Presence of photosensitive rash, often on sun-exposed areas, with characteristic annular or psoriasiform lesions.
Laboratory Tests: Positive antinuclear antibodies (ANA), often with specific anti-Ro/SSA antibodies.
Skin Biopsy: Histological examination may show interface dermatitis and vacuolar changes.
Differential Diagnosis: Exclude other causes of photosensitive rashes and drug eruptions.
Drug-Induced SCLE: Consider history of drug exposure, particularly anesthetics like propofol, as triggers. 1Management
First-Line Treatments:
- Hydroxychloroquine: Initial treatment, typically 200-400 mg/day.
- Topical Corticosteroids: For localized skin lesions.
Adjunctive Treatments:
- Systemic Corticosteroids: For severe cases, dose adjusted based on severity.
- Immunosuppressants: Mycophenolate mofetil or azathioprine in refractory cases.
Discontinuation of Triggering Agents: Remove identified drug triggers, such as propofol, if applicable. 1Special Populations
Pregnancy: Limited data; close monitoring and individualized management required. 1
Pediatrics: Rarely reported; management similar to adults but with cautious dosing.
Elderly: Consider comorbidities and potential drug interactions when selecting treatments.
Comorbidities: Tailor treatment considering other systemic conditions, especially renal involvement. 1Key Recommendations
Identify and Remove Triggering Agents: If drug-induced SCLE is suspected, discontinue the implicated drug (e.g., propofol). (Evidence: Expert opinion) 1
Initiate Hydroxychloroquine as First-Line Therapy: Use hydroxychloroquine at doses of 200-400 mg/day for managing SCLE symptoms. (Evidence: Expert opinion) 1
Monitor for Photosensitivity and Skin Lesions: Regular follow-up to assess response to treatment and adjust based on clinical improvement. (Evidence: Expert opinion) 1References
1 Schoenfeldt JA, Howard MA, Masood D, Cormican DS. Propofol Induced Subacute Cutaneous Lupus Erythematosus: A Case Report. A&A practice 2023. link